Month in pharma news, explained – May 2026 - EMJ GOLD
• In May 2026, pharmaceutical advancements focused on KRAS, a protein previously deemed "undruggable," with new research exploring the efficacy of the drug daraxonrasib. • A first-line study is currently underway to determine if daraxonrasib can be used earlier in treatment, either as a monotherapy or in combination with chemotherapy. • Public health concerns rose following an outbreak of the Andes strain of hantavirus linked to a Dutch cruise ship, which resulted in three deaths.
emjreviews.com